Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline-Reference-Cited by-同舟云学术

Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline

Published:2009-03 Issue:6 Volume:144 Page:895-903
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Richardson Paul G.,Sonneveld Pieter,Schuster Michael W.,Stadtmauer Edward A.,Facon Thierry,Harousseau Jean-Luc,Ben-Yehuda Dina,Lonial Sagar,Goldschmidt Hartmut,Reece Donna,Bladé Joan,Boccadoro Mario,Cavenagh Jamie D.,Boral Anthony L.,Esseltine Dixie-Lee,Wen Patrick Y.,Amato Anthony A.,Anderson Kenneth C.,San Miguel Jesus

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07573.x/fullpdf

Reference33 articles.

1. The proteasome: a suitable antineoplastic target;Adams;Nature Reviews. Cancer,2004

2. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant;Bladé;British Journal of Haematology,1998

3. Validity and selective sensitivity of the FACT-GOG Ntx;Calhoun;Journal of Clinical Oncology,2000

4. Clinical manifestations and current treatment options for diabetic neuropathies;Casellini;Endocrine Practice,2007

5. Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat;Cavaletti;Experimental Neurology,2007

Cited by 272 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer;Breast Cancer Research and Treatment;2024-05-07

2. The Current State of Integrated Treatment with Chinese and Western Medicine for Nerve Damage Associated with Multiple Myeloma;Advances in Clinical Medicine;2024

3. Reporting of adverse events of treatment interventions in multiple myeloma: an overview of systematic reviews;Annals of Hematology;2023-11-08

4. Toxic Neuropathies;CONTINUUM: Lifelong Learning in Neurology;2023-10

5. Inhibitors of the Mechanistic Target of Rapamycin Can Ameliorate Bortezomib-Induced Peripheral Neuropathy;Biological and Pharmaceutical Bulletin;2023-08-01